AUG 29, 2015 2:18 PM PDT

Virus Causes Liver Cancer

WRITTEN BY: Ilene Schneider
Viruses can be involved in the development of serious diseases. A case in point is liver cancer, which often develops in an organ that has been weakened by hepatitis B or C virus. 
Liver cancer is usually found in already damaged cells.
Researchers at Inserm, the Paris Public Hospitals (AP-HP), Paris Descartes University, Paris 13 University (USPC) and Paris Diderot University have identified the role of a new virus in a rare type of liver cancer. This study, based on follow-up and observation of 193 patients, is published in Nature Genetics and reported in Drug Discovery & Development

More than 8,000 new individuals are diagnosed with liver cancer every year. It mainly affects men and is a major cause of death worldwide. Of the different types, hepatocellular carcinoma usually occurs in a liver already damaged by illness. The liver may have been weakened by excessive alcohol consumption, obesity or chronic viral infection by hepatitis B or C viruses, causing irreversible liver lesions, ultimately culminating in cirrhosis.

While cirrhosis patients usually undergo regular tests to detect cancer, in 5 percent of cases, liver cancer occurs in patients who had not reported cirrhosis. Thus, the reason for developing the cancer is a mystery. Jessica Zucman-Rossi and her staff at Inserm Unit 1162, Functional Genomics of Solid Tumors, took a special interest in these patients to discover the risk factors that had contributed to the development of their cancer.

According to the report, “In the genome of tumor cells of 11 patients, the scientists observed the insertion of a viral DNA segment from adeno-associated virus type 2, known as AAV2. This virus has been considered non-pathogenic for humans until now. In order to confirm the virus's involvement in the cancer, the research team compared tumor tissues with normal tissues. They thus confirmed their hypothesis: the integration of viral DNA was found more often in tumor cells than in healthy cells in these 11 patients. Moreover, eight of these patients did not have cirrhosis, and six of them presented no known risk factors for liver cancer.

When they studied these malignant cells in greater detail, the researchers discovered that the virus, when putting its DNA into the genome of the patient's cells, targets genes important in cell proliferation. The researchers have demonstrated that AAV2 leads to excessive expression of these genes that may cause tumor development.

In this work, the researchers have identified the involvement of AAV2 virus, which used to be considered harmless, in the occurrence of hepatocellular carcinoma, especially in the rare cases of cancer that develop without cirrhosis or another identified cause. The researchers caution, "AAV2 is often used as a vector in gene therapy. Although the insertion of its DNA into tumor promoting genes is rare, and probably a chance event, precautions must be taken regarding the use of this virus."
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
DEC 23, 2019
Technology
DEC 23, 2019
Can Artifical Intelligence Detect Leukemia?
Artificial intelligence has always been a hot topic of discussion in the medical sciences with a whirlwind of applications. However, know the latest curios...
JAN 11, 2020
Cancer
JAN 11, 2020
Should we be concerned about talc powder and ovarian cancer?
After the outcry against baby powder and concerns regarding its link to ovarian cancer, still, no investigations have clearly linked the product to the dis...
FEB 12, 2020
Cancer
FEB 12, 2020
Can we eradicate cervical cancer within a century?
Two studies recently published in The Lancet present evidence that the eradication of cervical cancer could be possible within the next century. The World ...
FEB 19, 2020
Clinical & Molecular DX
FEB 19, 2020
Forget complicated scans - ovarian cancer can be detected in the blood
Results from clinical trials performed in Melbourne, Australia have revealed the diagnostic potential of a new test for ovarian cancer. Instead of using co...
FEB 19, 2020
Technology
FEB 19, 2020
Novel Technology Analyzes Single Cancer Cells
Recent technology may help for the first time to enable cancer scientists the analysis of individual behavior of millions of different cells living inside ...
FEB 24, 2020
Cancer
FEB 24, 2020
Could NRF2 trigger hepatomegaly?
Research published today in the Journal of Hepatology suggests that the protein responsible for antioxidant defenses in humans may adversely affect th...
Loading Comments...